Abstract
Background: The severe acute respiratory syndrome coronavirus 2 (SARs-CoV-2) has resulted in a global pandemic. Hydroxychloroquine±azithromycin have been widely used to treat coronavirus disease 2019 (COVID-19) despite a paucity of evidence regarding efficacy. The incidence of torsade de pointes remains unknown. Widespread use of these medications forced overwhelmed health care systems to search for ways to effectively monitor these patients while simultaneously trying to minimize health care provider exposure and use of personal protective equipment.
Methods: Patients with COVID-19 positive who received hydroxychloroquine±azithromycin across 13 hospitals between March 1 and April 15 were included in this study. A comprehensive search of the electronic medical records was performed using a proprietary python script to identify any mention of QT prolongation, ventricular tachy-arrhythmias and cardiac arrest.
Results: The primary outcome of torsade de pointes was observed in 1 (0.015%) out of 6476 hospitalized patients with COVID-19 receiving hydroxychloroquine±azithromycin. Sixty-seven (1.03%) had hydroxychloroquine±azithromycin held or discontinued due to an average QT prolongation of 60.5±40.5 ms from a baseline QTc of 473.7±35.9 ms to a peak QTc of 532.6±31.6 ms. Of these patients, hydroxychloroquine±azithromycin were discontinued in 58 patients (86.6%), while one or more doses of therapy were held in the remaining nine (13.4%). A simplified approach to monitoring for QT prolongation and arrythmia was implemented on April 5. There were no deaths related to the medications with the simplified monitoring approach and health care provider exposure was reduced.
Conclusions: The risk of torsade de pointes is low in hospitalized patients with COVID-19 receiving hydroxychloroquine±azithromycin therapy.
Keywords: COVID-19; azithromycin; hydroxychloroquine; pandemic; torsade de pointes.
【저자키워드】 COVID-19, pandemic, Azithromycin, Hydroxychloroquine, torsade de pointes., 【초록키워드】 coronavirus disease, Personal protective equipment, Coronavirus disease 2019, Efficacy, coronavirus, therapy, Health care, Azithromycin, Hydroxychloroquine, hospital, risk, medications, hospitalized patients, severe acute respiratory syndrome Coronavirus, Cardiac arrest, global pandemic, QT prolongation, Health, Patient, Python, death, incidence, respiratory, electronic medical records, medication, Health care system, Arrhythmias, Care, patients, QTc, Evidence, dose, health care systems, medical records, Torsade de Pointes, care provider, acute respiratory syndrome, Primary outcome, acute respiratory syndrome coronavirus, average, arrythmia, treat, positive, MONITOR, approach, electronic medical record, identify, nine, receiving, was performed, hospitalized patient, was reduced, baseline, ventricular, with COVID-19, 【제목키워드】 QTc, System, Administering, Potential,